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Infectious hepatitis C virus (HCV) particle production in the genotype 2a JFH-1-based cell culture
system involves non-structural proteins in addition to canonical virion components. NS2 has been
proposed to act as a protein adaptor, co-ordinating the early stages of virion assembly. However,
other studies have identified late-acting roles for this protein, making its precise involvement in
infectious particle production unclear. Using a robust, bipartite trans-encapsidation system based
upon baculovirus expression of HCV structural proteins, we have generated HCV-like particles
(HCV-LP) in the absence of NS2 with overt similarity to wild-type virions. HCV-LP could
transduce naive cells with trans-encapsidated subgenomic replicon RNAs and shared similar
biochemical and biophysical properties with JFH-1 HCV. Both genotype 1b and JFH-1
intracellular HCV-LP were produced in the absence of NS2, whereas restoring NS2 to the JFH-1
system dramatically enhanced secreted infectivity, consistent with a late-acting role. Our system
recapitulated authentic HCV particle assembly via trans-complementation of bicistronic, NS2-
deleted, chimeric HCV, which is otherwise deficient in particle production. This closely resembled
replicon-mediated NS2 trans-complementation, confirming that baculovirus expression of HCV
proteins did not unduly affect particle production. Furthermore, this suggests that separation of
structural protein expression from replicating HCV RNAs that are destined to be packaged
alleviates an early stage requirement for NS2 during particle formation. This highlights our current
lack of understanding of how NS2 mediates assembly, yet comparison of full-length and bipartite
systems may provide further insight into this process.
INTRODUCTION
Hepatitis C virus (HCV) represents a global health challenge
with a prevalence of over 3% worldwide. Chronic infection
leads to severe liver disease in many cases, including
cirrhosis and hepatocellular carcinoma. Despite the devel-
opment of an HCV infectious culture system based on the
genotype 2a JFH-1 isolate (Kato et al., 2003; Wakita et al.,
2005), the way in which infectious particles are both
assembled and secreted from infected cells remains poorly
characterized.
HCV is an enveloped virus with a 9.6 kb positive sense
ssRNA genome belonging to the Flaviviridae. An internal
ribosome entry site (IRES) present within the 59 UTR
drives translation of a ~3000 aa polyprotein that is cleaved
by both host and viral proteases yielding 10 mature
products. The core (C) and envelope proteins (E1 and E2)
along with the RNA genome are thought to be the major
virion components, whilst the non-structural (NS) proteins
3, 4A, 4B, 5A and 5B are both necessary and sufficient to
form the viral RNA replication complex. Two proteins, p7
and NS2, do not easily fall within either category.
It is increasingly clear that HCV non-structural proteins
co-operate with the canonical virion components during
infectious particle production. NS2 has been proposed to
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act both at early and late times during this process. The
early role for NS2 is thought to involve its ability to act as a
protein adaptor (Jirasko et al., 2008, 2010; Ma et al., 2011;
Stapleford & Lindenbach, 2011), meditating interactions
between both structural (e.g. E2) and other non-structural
proteins (e.g. NS3, NS5A). This function is, in turn,
dependent on a genotype-specific interaction with p7,
which targets NS2 to punctae within infected cells (Jirasko
et al., 2010; Popescu et al., 2011; Tedbury et al., 2011), and
the two proteins together also modulate core protein
localization (Boson et al., 2011). Co-localization analyses
show that NS2 punctae contain other HCV non-structural
proteins such as NS5A, which, complemented by inter-
action data, have led to the proposal that they represent
sites of virion assembly. Accordingly, point mutations that
disrupt these interactions also prevent punctae formation
and abrogate intracellular infectivity, although whether
non-infectious particles are formed within cells is not
known.
Evidence for a late-acting role for NS2 includes detection of
non-infectious core-containing intracellular particles in cells
harbouring chimeric H77/JFH-1 HCV with a deleterious
NS2 S168A mutation (Yi et al., 2009). Restoration of
infectivity in this context was achieved by NS2 expression in
trans, and was also genotype dependent. More recently,
studies of the NS2 N-terminal region identified a subset
of point mutants with particle production defects specific
to virion egress rather than assembly; accumulation of
intracellular infectivity was unaffected (de la Fuente et al.,
2013). Thus, NS2 appears to play a complex role during
virion morphogenesis, potentially involving more than one
essential function.
It is well established that the canonical HCV structural
proteins (core, E1, E2), expressed in multiple contexts, can
form HCV-like particles (HCV-LP) that physically resemble
wild-type HCV (wtHCV) (Baumert et al., 1998; Kunkel et al.,
2001; Owsianka et al., 2001; Saunier et al., 2003; Triyatni et al.,
2002; Wellnitz et al., 2002; Xiang et al., 2002). Thus, de novo
capsid formation and envelopment are not dependent on NS2
in these systems. However, further studies report a dependence
on NS2 for the formation of secreted HCV-LP capable of
delivering packaged replicon RNA to naive cells: so-called
pseudo-infection (Adair et al., 2009; Ishii et al., 2008;
Steinmann et al., 2008). This leaves the intriguing possibility
that, in the absence of NS2, the intracellular compartment
harbours HCV-LP produced by trans-encapsidation that are
capable of pseudo-infection.
Here, we show that functional intracellular HCV-LP capable
of pseudo-infection are generated by a bipartite trans-
encapsidation system lacking NS2. HCV-LP resembling
particles produced by full-length HCV clones were formed
by both genotype 1b and a more vigorous genotype 2a JFH-1
system. Reintroduction of NS2 into the JFH-1 context led to
a significant increase in secreted infectivity, consistent with
the restoration of a late-acting function in this trans-
encapsidation setting.
RESULTS
NS2 is dispensable for intracellular HCV-LP
formation by genotype 1b HCV
We first examined whether ‘empty’ HCV-LP, reminiscent
of those produced in Sf9 cell studies (Baumert et al., 1998),
could be generated by transduction of Huh7 cells with a
baculovirus encoding a genotype 1b C-E1-E2-p7 expression
cassette [BacC-p7(1b)] (Fig. 1a). To demonstrate biochem-
ically the presence of enveloped particles, detergent-free
lysates prepared from transduced Huh7 cells were incubated
with recombinant CD81 large extracellular loop (LEL) fused
to maltose binding protein (MBP–CD81) in order to
precipitate HCV-LP via the E2/CD81-receptor/ligand inter-
action (Chan-Fook et al., 2000). Western blotting of bound
fractions demonstrated the presence of both E2 and core in
lysates transduced by BacC-p7(1b), but not a Bac-LacZ
control (Fig. 1b). HCV proteins were not detectable in
supernatants (data not shown). Next, lysates were partially
purified through a sucrose cushion and then separated by
sucrose gradient ultracentrifugation. MBP–CD81 was used
either as a probe for E2-containing fractions bound to an
ELISA plate (Fig. 1c, top graph), or to coat plates and serve
as an immobilized trap for E2 within gradient fractions (Fig.
1c, bottom graph). In each case, a broad peak of reactivity
absent from controls was detected, consistent with partic-
ulate material partitioning within the density gradients.
Next, we investigated whether intracellular HCV-LP could
encapsidate replicon RNA and mediate pseudo-infection
using a bipartite trans-encapsidation system employing
baculovirus transduction [BacC-p7(1b)] of Huh7 cells
carrying the culture-adapted FK5.1neo replicon (Krieger
et al., 2001) encoding NS3-5B (Fig. 2a). MBP–CD81 pull-
downs from detergent-free lysates of BacC-p7(1b)-trans-
duced Huh7 or Huh7 FK5.1neo cells demonstrated the
presence of correctly folded E2 in close association with
core protein (Fig. 2b), suggestive of particle formation.
The composition and structure of potential HCV-LP was
next investigated by immunoprecipitation. Consistent
with the presence of intact enveloped virions, detergent
disrupted the ability of anti-E2 antibodies to precipitate
either core protein (Fig. 2c) or replicon RNA (Fig. 2d).
Similarly, anti-E2 antibodies did not precipitate replicon
RNA from cells transduced with a baculovirus lacking the
core protein, BacE1-p7(1b), excluding the possibility of
exosomal transfer of replicon RNAs (Fig. 2c). In addition,
replicon RNA was only precipitated by anti-core antibodies
in the presence of detergent, excluding non-enveloped
capsids from mediating RNA transfer (Fig. 2d).
HCV-LP pseudo-infection was then assessed by G418-resistant
colony formation in naive Huh7 cells transduced with either
secreted or intracellular HCV-LP preparations. Each experi-
ment was conducted upon the same batch of the replicon-
bearing stable cell line, ensuring equivalent RNA copies per cell
between transductions. Whilst pseudo-infectivity was absent
from the supernatants of BacC-p7(1b)-transduced Huh7
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FK5.1neo cells (data not shown), intracellular infectivity
released by detergent-free lysis was readily detectable by
colony formation assay (Fig. 2e). This was not the case for
control baculoviruses BacLacZ or BacE1-p7(1b). Further-
more, selected individual colonies expanded under selection
were shown tomaintain replicon RNA by Northern blot (data
not shown).
The presence of intracellular HCV-LP within producer cells
was examined by thin section transmission electron micro-
scopy (TEM) (Fig. 2f). Membrane rearrangements were
evident within replicon cells, including those transduced with
BacE1-p7(1b), yet particles were only evident within cells
both harbouring replicon RNA and transduced by BacC-
p7(1b). Interestingly, these particles were concentrated within
distended intracellular vesicles, consistent with a potential
block to secretion. On the basis of evidence from immuno-
precipitation experiments, we attest that electron-dense entities
are likely to represent HCV-LP, assembled in the absence of
NS2.
Intracellular RNA-containing HCV-LP were next analysed
by sucrose density gradient ultracentrifugation (Fig. 3a).
HCV E2 ELISA indicated a broad peak of particulate material
towards the top of the gradient, which we showed to contain
E2 and core (by Western blot), replicon RNA [by reverse
transcriptase (RT)-PCR], and pseudo-infectivity (colony
formation). Furthermore, TEM analysis of peak gradient
fractions revealed the presence of enveloped particles with
diameters of around 50 nm (Fig. 3b). Some HCV-LP con-
tained a clearly identifiable core as well as prominent envelope
spike proteins. Equivalent particles were not observed in
control gradients from LacZ-transduced cells, or within non-
peak fractions from the BacC-p7(1b)-transduced cells (data
not shown). Thus, pseudo-infectious genotype 1b HCV-LP
assemble within cells in the absence of NS2 but are not
secreted, and are reminiscent of particles produced in anal-
ogous systems as well as authentic wtHCV virions.
JFH-1 HCV-LP are assembled, but not efficiently
secreted in the absence of NS2
Given our observation that intracellular genotype 1b HCV-
LP could form in the absence of NS2, we examined whether
this was also the case in an analogous JFH-1 bipartite
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Fig. 1. Formation of intracellular particles in GT1b system lacking NS2. (a) Diagram of genotype 1b C-p7 baculovirus construct.
(b) MBP–CD81 pull-down from detergent-free lysate derived from transduced Huh7 cells as indicated. MBP–CD81 was
incubated with lysates and the complexes were pulled down on amylose beads. Bound material was assayed for the presence
of E2 and core by immunoblot (IB). (c) Top graph, indirect ELISA for MBP–CD81 performed on fractionated gradients of
detergent-free BacC-p7/Huh7 lysates. BacC-p7/Huh7 lysates were partitioned on sucrose gradients, which were
subsequently fractionated and 100 ml of each fraction was bound to one well of an ELISA plate. Post-washing, each was
incubated with MBP–CD81, which was subsequently detected with rabbit anti-MBP, followed by goat anti-rabbit-HRP. Bottom
graph, MBP–CD81 was bound to the ELISA plate, which was subsequently incubated with 100 ml of each fraction. Detection
was carried out using mouse anti-E2 (AP33) followed by anti-mouse-HRP. X, Huh7 + Cp7; m, Huh7 + LacZ.
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system, assessing HCV-LP pseudo-infectivity by focus-
forming assay. Consistent with genotype 1b experiments,
transduction of Huh7 cells transiently electroporated with
the JFH-1 NS3-5B replicon with BacC-p7(2a) or BacC-
NS2(2a) revealed no statistically significant differences
(P50.082554) in pseudo-infectivity within cell lysates
lacking NS2, compared with those where NS2 was present
(Fig. 4a). Pseudo-infectivity did not directly correlate with
levels of baculovirus-expressed protein; BacC-NS2(2a)
showed markedly reduced expression levels compared
with BacC-p7(2a) as noted previously (Adair et al., 2009;
Bentham et al., 2013) (Fig. 4b). Low levels of secreted
pseudo-infectivity were present for transductions lacking
NS2, yet inclusion of NS2 had a profound effect on
pseudo-infectivity within the secreted compartment, with
highly significant (.2 log10, P,0.0005) increases in
titre (Fig. 4a). Interestingly, levels of pseudo-infectivity
appeared to be independent of whether NS2 was present
upon the replicon or the baculovirus, despite low
expression levels of BacC-NS2(2a). Furthermore, Western
blot analysis of NS2 revealed a high propensity for NS2 to
exist in its truncated (t) form where p7 was absent (Fig.
4b). This may relate to a requirement for p7 to stabilize
NS2 resulting from their trans-interaction. Indirect immu-
nofluorescence for core and NS5A confirmed the presence
of cells co-expressing both replicon and baculovirus
proteins in each set of conditions (Fig. 4c).
JFH-1 HCV-LP resemble infectious JFH-1 wtHCV
To show that HCV-LP resembled infectious JFH-1 particles,
we partially purified either clarified supernatants or deter-
gent-free cell lysates through sucrose cushions prior to com-
paring buoyant density/infectivity profiles following centrifu-
gation to equilibrium through isopycnic iodixinol density
gradients (Fig. 4d). HCV-LP produced by a combination of
BacC-p7(2a) and the NS2-NS5B replicon displayed a near-
identical profile to that of JFH-1, with peak infectivity ranging
from ~1.1 to 1.15 gml21. As for JFH-1, the majority of HCV-
LP infectivity was present within the secreted compartment.
Consistent with bulk infectivity measurements (Fig. 4a), levels
of secreted infectious HCV-LP produced in the absence of
NS2 were much lower than those formed in its presence (Fig.
5, top panel). Nevertheless, core protein was detectable in the
peak fractions from gradients of particles formed in the
absence of NS2 (Fig. 5, lower panel). However, the reduction in
protein levels was not proportionate to the loss of infectivity,
suggesting that the specific infectivity of secreted HCV-LP
may have been affected. It is also not possible to rule out that
HCV-LP present within the secreted compartment result
from cell lysis liberating particles that might not otherwise
be efficiently secreted.
Characterization of intracellular JFH-1 HCV-LP
formed in the absence of NS2
We next compared intracellular JFH-1 HCV-LP produced
in the presence/absence of NS2. Detergent-free lysates of
transfected/transduced Huh7 cells were purified through a
sucrose cushion, and then subjected to iodixinol gradient
analysis as above. A peak of infectivity was present near the
centre of the gradient (Fig. 6a, top panel), although particles
formed in the absence of NS2 displayed a slightly higher
peak buoyant density (~1.2 compared with 1.15 g ml21).
Similarly, peak fractions contained core protein in relative
proportion to respective loading controls, indicating that
organization of core into capsid structures was not adversely
affected by the lack of NS2.
Critically, HCV-LP produced in the absence of NS2 were
equally sensitive to antibody-mediated blockade of virus
entry compared with those generated when the protein was
present. Both titration of anti-E2 (AP33, Fig. 6b) and
blockade of cellular CD81 (Fig. 6c) resulted in similar levels
of inhibition for both secreted and intracellular particles
produced when NS2 was present, as well as for intracellular
virions produced in its absence. Thus, intracellular NS2-
deficient HCV-LP enter and productively pseudo-infect
Huh7 cells via an analogous route to authentic HCV.
Context-dependent formation of intracellular
particles in the absence of NS2
Our observation that NS2 is not required for the generation
of pseudo-infectious intracellular HCV-LP notably differs
from published studies where infectivity was absent from
bicistronic HCV expressing structural proteins (C-p7) in
cistron 1 and the viral replicase (NS3-5B) in cistron 2. It
was therefore important to reproduce these data to verify
that, in our hands, similar defects in the production of
HCV-LP were observed. Consistent with previous reports,
Fig. 2. GT1b particles form in the absence of NS2, package replicon RNA and pseudo-infect naive Huh7 cells. (a) Diagram of
genotype-1b-expressing baculoviruses and the FK5.1neo replicon. (b) MBP–CD81 pull-down from FK5.1 replicon-containing
cells transduced with baculoviruses as indicated. Pull-downs were blotted for either E2 or core. (c) Immunoprecipitation of HCV
material from FK5.1neo cell lysates, transduced with baculoviruses as indicated, in the presence/absence of 0.5% NP-40
detergent. IP, immunoprecipitation; IB, immunoblot; asterisk denotes non-specific band detected by anti-GT1b core antibody;
arrows highlight band of interest for each immunoblot. (d) HCV-specific reverse transcriptase (RT)-PCR on material
immunoprecipitated as described for (c). RT, reverse transcriptase;+ve, in vitro transcribed replicon RNA positive control; ”ve,
water negative control. (e) Huh7 colonies selected with G418 (1 mg ml”1) following pseudo-infection with replicon cell lysates
post-transduction with baculoviruses as indicated. (f) Thin section transmission electron microscopy of Huh7 or FK5.1neo cells
transduced with baculoviruses as indicated. N, nucleus; M, mitochondrion; LD, lipid droplet; bars as indicated (calculated).
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transfection of J6/JFH-1-DNS2-IRES-NS3 (Fig. 7a) into
Huh7 cells failed to generate infectious intracellular or
secreted particles, in contrast to its infectious full-length
genome counterpart (Fig. 7b, c). Reassuringly, provision
of NS2 in trans, either via co-transfection with an NS2-
5B JFH-1 replicon RNA (Fig. 7b), or BacC-NS2(JFH-1)
transduction (Fig. 7c), resulted in the formation of
infectious J6/JFH-1-DNS2-IRES-NS3 particles. Given the
similar efficiency of complementation achieved using these
two systems, we conclude that baculovirus transduction
does not perturb the cellular machinery in a manner
that might interfere with the assembly process. This was
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Fig. 3. Direct analysis of intracellular HCV-LP on sucrose density gradients. (a) Anti-E2 ELISA using ALP98 mouse monoclonal
antibody conducted on fractions from a 10–60% (w/v) sucrose density gradient from C-p7-transduced FK5.1neo cell lysates.
Western blots for HCV proteins and RT-PCR for HCV RNA are shown underneath for each fraction, along with colony formation
assays for the top 12 fractions. (b) Negative-stain TEM of peak gradient fraction (4) revealing HCV-LP. Bars, 100 nm.
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confirmed by the observation that BacC-p7(JFH-1) trans-
duction was unable to restore particle production to J6/
JFH-1-DNS2-IRES-NS3 transfected cells (Fig. 7c). Our
results therefore support that intracellular HCV-LP particle
production in the absence of NS2 is a genuine phenom-
enon, but is dictated by the context in which the RNA to be
packaged expresses viral proteins. Finally, we assessed which
RNAs were encapsidated into newly formed particles during
trans-complementation assays by staining infected cells for
NS5A, core and neomycin phosphotransferase (NPT). As
seen for NS5A trans-complementation experiments (Appel
et al., 2008), infected cells contained both chimeric HCV as
well as subgenomic replicon RNAs, as evidenced by a lack of
core staining (Fig. 8a) and the presence of NPT (Fig. 8b)
within NS5A-positive foci (white arrows depict single-
labelling cells in each instance).
DISCUSSION
This study demonstrates that NS2 is not required for the
formation of HCV-LP in a bipartite assembly system where
baculovirus-expressed HCV structural proteins package
subgenomic replicon RNA. This applies to both genotype
1b HCV, and the cell culture infectious JFH-1 isolate
which belongs to genotype 2a. However, efficient secretion
of HCV-LP from the cell only occurs when NS2 is present
in the genotype 2a JFH-1 context. HCV-LP produced in
the presence or absence of NS2 appear to share broadly
similar characteristics and are equally ‘pseudo-infectious’,
as defined by their ability to transfer subgenomic replicon
RNAs to naive Huh7 cells in an E2/CD81 dependent
fashion. Interestingly, to our knowledge, this is the first
demonstration of pseudo-infectious genotype 1b HCV-LP,
which was unexpected due to the presence of cell-culture-
adaptive mutations within the FK5.1neo replicon that
reduce particle formation in a full-length CON-1 context
(Pietschmann et al., 2009). This alludes to potential
differences in particle production in cis vs trans encapsida-
tion settings.
Mutations within NS2 have been identified that modulate
several processes linked to the production of infectious HCV
particles, including interactions with other HCV proteins,
targeting to cytoplasmic foci, and, together with p7,
influencing the localization of core protein (Boson et al.,
2011; Jirasko et al., 2008, 2010; Ma et al., 2011; Popescu et al.,
2011; Stapleford & Lindenbach, 2011; Tedbury et al., 2011).
The combination of these functions with the loss of
intracellular infectivity has led to the hypothesis that NS2
forms an assembly scaffold within cells, co-ordinating early
events of virion morphogenesis. However, two studies also
support post-assembly roles for NS2 during infectious particle
production, namely the identification of non-infectious H77/
JFH-1 chimeric particles carrying an NS2 S168A mutation (Yi
et al., 2009), and the generation of N-terminal NS2 point
mutants with defects in particle egress (de la Fuente et al.,
2013). These studies were carried out primarily in the context
of bicistronic full-length HCV clones, where NS2 and NS3 are
separated by an IRES and deletion of NS2 abrogates infectivity
in all compartments (Jones et al., 2007). However, omission of
NS2 from our bipartite system resembles the scenario seen for
the N-terminal mutants, where secreted, but not intracellular
infectivity is significantly reduced. The mechanism by which
trans-encapsidation bypasses the requirement for NS2 at an
early stage remains unknown, yet seems unlikely to involve
overexpression artefacts as protein levels were similar to those
observed following electroporation of full-length JFH-1 RNA
and baculovirus-expressed proteins were able to rescue NS2-
deleted full-length bicistronic HCV in trans.
It is interesting to note that bicistronic viruses such as J6/
JFH-1-(DNS2)-IRES-NS3 differ from subgenomic repli-
cons by expression of the HCV structural proteins, C-p7, in
place of luciferase or NPT in the first cistron. Thus, when
C-p7 is expressed from a replicating, NS2-deleted HCV
RNA, which would otherwise ultimately be destined to be
packaged, this appears to prevent the ability of those same
structural proteins expressed in trans to rescue particle
production (see Fig. 7c). This does not appear to be due
to the availability or accessibility of C-p7 within these
cells as provision of NS2 leads to trans-encapsidation
of replicon RNAs (Fig. 8). Accordingly, our study shows
that separation of C-p7 expression from replicating NS2-
deleted RNAs allows particle formation to proceed, and
reveals a late-stage NS2 defect during secretion, which has
also been observed in mutagenesis studies (de la Fuente
et al., 2013; Yi et al., 2009). Interestingly, neither the origin
of NS2 (replicon/bicistronic virus/baculovirus), nor
limited expression levels [e.g. BacC-NS2(JFH-1)] appear
to adversely affect its ability to rescue particle production/
secretion in either scenario. This lack of positional
dependence may relate to the initial widespread cytoplas-
mic distribution of NS2 at early times post-infection/
transfection, with targeting to foci occurring much later
(Jirasko et al., 2010). Taken together, these observations
support the notion that distinct pools of replicated/
translated/packaged HCV RNA might exist within the cell,
and that NS2 may regulate their composition via its
multiple protein–protein interactions, in particular the
HCV RNA-binding protein, NS5A. Accordingly, NS5A
trans-complementation studies discriminate between require-
ments for particle assembly and replication (Herod et al.,
2014), and the pharmacokinetics of the NS5Ai, Daclatasvir,
support distinct RNA pools for packaging and replication
(McGivern et al., 2014).
The trans-interaction between NS2 and p7 appears to be
integral to the function of both proteins during particle
production. This interaction results in p7-mediated target-
ing of NS2 to punctae (Jirasko et al., 2008, 2010; Ma et al.,
2011; Popescu et al., 2011; Tedbury et al., 2011), which may
also influence NS2 stability; several mutations that disrupt
p7/NS2 interactions also increase the abundance of tNS2
within cells (Jirasko et al., 2008, 2010) and we also observed
this to occur where NS2 was expressed separately from C-p7.
The precise nature of tNS2 is uncertain, but proteasomal
HCV assembly without NS2
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degradation of NS2 is thought to be mediated by casein
kinase(II)-mediated phosphorylation of Ser168 (Franck
et al., 2005). However, the effects of S168A mutations
appear to be genotype-dependent, abrogating infectivity in
H77/JFH-1 but not JFH-1 (Yi et al., 2009), although both
NS2 localization and its NS5A interaction are disrupted in
the latter case (Tedbury et al., 2011). However, localization
of NS5A to punctae is unaffected by mutations disrupting
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HCV-LP generated in the absence/presence of NS2 (see diagram) following isopycnic density gradient ultracentrifugation in a
10–40% iodixinol/PBS gradient. Bottom, core immunoblot of methanol-precipitated gradient fractions.
in each. P values were generated using Student’s t-test. Bottom, expression of replicon (NS5A)- and baculovirus (core)-derived
proteins along with GAPDH loading control. (b) Immunoblot showing expression of NS2 in relation to core and NS5A in
transduced, replicon-expressing Huh7 cells. (c) Indirect immunofluorescence of replicon (NS5A)- and baculovirus (core)-
derived proteins. NS5A is shown in the red channel (594 nm), core in green (488 nm) and nuclei counter-stained using
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HCV assembly without NS2
http://vir.sgmjournals.org 2435
p7/NS2 interactions, suggesting that NS2 does not drive
punctae formation (Popescu et al., 2011; Tedbury et al.,
2011). H77/JFH-1-S168A viruses in the above study also
assembled non-infectious particles, consistent with our
observation that C-p7 alone is sufficient to assemble virions
within Huh7 cells. Combined with NS2 point mutations
identified as being specific to particle secretion rather than
early events (de la Fuente et al., 2013), the function of this
protein appears complex, context-dependent and largely
undefined. However, combinations of cis and trans systems
may provide further insight into how this protein regulates
both particle formation and release.
Regarding a potential secretory role, Ser 168 phosphoryla-
tion is thought to mediate NS2 ubiquitylation, targeting
it for proteasomal degradation. However, mutagenesis of
NS2 lysine residues affected infectious particle production,
rather than NS2 stability (Welbourn et al., 2009). One
alternative outcome of protein ubiquitylation is to recruit
protein cargo into the endosomal sorting complex required
for transport, or ‘ESCRT’ pathway (Babst et al., 2002a, b;
Katzmann et al., 2001), which we and others have shown to
influence the secretion of infectious HCV particles (Ariumi
et al., 2011; Corless et al., 2010). ESCRT factors are critical
for the secretion of many enveloped viruses, mediating
final membrane scission events during budding. Whilst the
involvement of NS2 in such processes is unknown, it
is interesting to note that mutations of the p7 basic
loop region have recently been shown to disrupt particle
envelopment (Gentzsch et al., 2013). However, such p7
mutations also disrupt NS2 stability and localization via
effects on E2-p7-NS2 precursors (Bentham et al., 2013;
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Steinmann et al., 2007; Tedbury et al., 2011). It is therefore
possible that envelopment defects were in part caused by
disruption of an NS2-ESCRT interaction, explaining its
late-acting functions identified both herein and by others
(de la Fuente et al., 2013).
In summary, we have exploited a robust trans-encapsida-
tion system to demonstrate differential requirements for
NS2 during infectious particle production. Detailed
comparison between bicistronic full-length and trans-
encapsidation systems may provide further insight into
the seemingly context-dependent, complex role played by
this protein during the HCV life cycle.
METHODS
Plasmids, viral clones and recombinant baculoviruses. pJFH-1
(Wakita et al., 2005), pJ6/JFH-1WT/DNS2-IRES-NS3 (Jones et al.,
2007), pFK5.1neo (Krieger et al., 2001) and subgenomic JFH-1
replicons encoding p7-NS5B and NS2-NS5B (Tedbury et al., 2011)
have been described previously. Baculoviruses expressing JFH-1 C-p7
and C-NS2 have also been described previously (Adair et al.,
2009). Passage 1 (P1) stocks were prepared by identical methods,
but P3 stocks were generated commercially by Oxford Expression
Technologies. Baculoviruses expressing genotype 1b C-p7/E1-p7 were
generated identically to those expressing JFH-1 structural proteins
using pCV-J4L6S (Yanagi et al., 1998) as a template and specific
primers. Details are available upon request.
Cell and virus culture. Huh7 cells were maintained and transfected
with replicon and wt full-length JFH-1-derived RNAs as described
previously (Griffin et al., 2008). Huh7 cells harbouring the GT1b
replicon (FK5.1neo) were maintained in Dulbecco’s minimal essential
medium supplemented with 250 mg G418 ml21 (Life Technologies).
For baculovirus transduction, Huh7 FK5.1neo cells were inoculated
with appropriate GT1b P3 baculovirus (or control wt-LacZ) at an
m.o.i. of 100–200 p.f.u. per cell and incubated for 96 h. Cell lysates
were prepared by sonication (or freeze–thaw for genotype 2a) in TNE
buffer (50 mM Tris, 50 mM NaCl, 0.5 mM EDTA, pH 7.5),
supplemented with protease inhibitors, then clarified by low speed
centrifugation (15 min, 900 g). For colony formation assays, naive
Huh7 cells were inoculated directly with clarified lysates as described
previously (Foster et al., 2011), and pseudo-infected cells were
selected using 1 mg G418 ml21, final concentration. G418-resistant
colonies became visible after 2 weeks, at which point they were fixed
in methanol and stained with Coomassie blue. Baculovirus (m.o.i. 10)
transduction of JFH-1 replicons was at 18 h post electroporation
and cells/supernatants were harvested at 72 h post-transfection.
Supernatant HCV-LPs (or wt virus) were clarified at 1000 g and
quantified by focus-forming assay. Intracellular virus was prepared
by four cycles of freeze/thaw lysis in PBS (250 ml), as described
previously (Foster et al., 2011).
Protein analysis. Antibodies used in this study were as follows:
rabbit anti-core polyclonal serum (308 or R412), mouse anti-E2
monoclonal [AP33 and ALP98 (Flint et al., 1999; Owsianka et al.,
2001)], rabbit polyclonal NS2 antiserum (Jirasko et al., 2010), sheep
anti-NS5A polyclonal serum (Macdonald et al., 2003), mouse anti-
GAPDH monoclonal (6C5, Abcam), mouse anti-neomycin phospho-
transferase 2 (4B4D1/ab60018, Abcam), mouse anti-CD81 (human)
(BD Pharmingen), and rabbit-anti-MBP (NEB). Appropriate HRP-
conjugated secondary antibodies were obtained from Sigma. Alexa-
fluor conjugated secondary antibodies were obtained from Invitrogen.
For Western analysis, Huh7 cells were lysed in enriched broth culture
(EBC) lysis buffer, then subjected to SDS-PAGE and Western analysis
as described previously (Griffin et al., 2008). AP33 was used in
the antibody neutralization assay along with an appropriate isotype
control.
Recombinant CD81 large extracellular loop (LEL) fused to maltose
binding protein (MBP–CD81) was expressed and purified as
described by Chan-Fook et al. (2000). MBP–CD81 fusion protein
(3.75 mg) was incubated with 450 ml cell lysate samples at 4 uC for
1 h. Amylose resin (100 ml; NEB) as a 1 : 5 slurry in TNE buffer
[100 mM Tris/HCl (pH 7.4), 150 mM NaCl, 5 mM EDTA] was
added, and further incubated for 4 h. The resin was extensively
washed in TNE buffer, boiled in sample loading buffer, clarified, and
subjected to SDS-PAGE prior to Western blotting. For co-immuno-
precipitation of E2 and core from the GT1b trans-encapsidation
experiments, cleared cell lysate was incubated with specified antibody
and complexes were captured on protein-G agarose beads (Life
Technologies). After incubation (4 uC, 4 h) beads were repeatedly
washed in TNE buffer, before the proteins were released by boiling
in SDS sample buffer. Proteins were analysed by SDS-PAGE and
Western blot. NP-40 (0.1% final concentration) was added to the
cleared lysate and included in subsequent steps as indicated.
Detection of HCV RNA. Detection of HCV-specific RNA (59 UTR,
primer sequences available on request) from HCV-LP concentrated
by immunoprecipitation/pull-down or from within gradient frac-
tions was achieved by extraction with Trizol reagent (Gibco Life
Technologies), followed by treatment with DNase I (RQI, Promega)
prior to RT-PCR using Superscript reverse transcriptase (Gibco Life
Technogies) following the manufacturer’s instructions.
Purification of secreted and intracellular HCV-LP. For intracel-
lular HCV-LP, clarified cell lysates were first diluted to 10 ml with
PBS and then partially purified by centrifugation at 150 000 g through
a 2 ml 20% sucrose cushion (w/v in PBS) for 4 h at 4 uC in a
Sorvall TH-641 rotor. Extracellular HCV-LP were purified identically
from 10 ml clarified culture supernatant. The resulting pellet was
resuspended in 250 ml PBS and samples were taken for titre
determination and Western blot analysis (input on Fig. 6a).
Genotype 1b HCV-LP cushion-purified lysates were layered over a
20–60% (w/w) sucrose gradient in PBS (pH 7.4) and centrifuged in a
Sorvall OTD65B (TH-641 rotor) for 22 h at 150 000 g. Twenty
fractions were collected from the top and analysed by SDS-PAGE; a
small portion of each was retained for TEM analysis. JFH-1 replicon
trans-encapsidated particles and/or wt JFH-1 virus were purified on a
preformed 12 ml iodixinol (10–40%, w/v, in PBS) gradient and
centrifuged in a Sorvall TH-641 rotor for 17 h at 80 000 g. Twenty-
two equal fractions were taken; 10 ml of each was titrated on naive
Huh7 cells by focus-forming assays. Alternatively, samples of each
Fig. 7. Trans-complementation of NS2-deleted HCV using baculovirus-expressed structural proteins and NS2. (a) Schematic
of chimeric HCV with NS2/3 expression separated by an IRES, incorporating deletion of the complete NS2 region (Jones et al.,
2007). (b) Rescue of NS2-deleted HCV using subgenomic replicon RNAs (full-length : replicon ~1 : 1 molar ratio). Infectivity
determined by focus-forming assay at 72 h post-electroporation, protein expression in producer cell lysates assessed by
Western blot utilizing antibodies as indicated. (c) As for (b), but with rescue provided by baculoviruses either expressing or
lacking NS2 alongside structural proteins.
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fraction were mixed with an equal volume of 4% paraformaldehyde/
PBS prior to TEM analysis. Ice-cold methanol was added to the
remainder of each fraction (3 : 1) and proteins precipitated at 220 uC
for 18 h. Precipitated proteins were recovered by centrifugation
(13 000 r.p.m., bench top microfuge, 4 uC), supernatants removed
and pellets resuspended in SDS-PAGE loading buffer, prior to
Western blot analysis.
Electron microscopy. Selected gradient fractions were prepared for
TEM by a uranyl acetate staining procedure on nickel carbon-coated
grids. Selected fractions (3–10 ml) were applied to Formvar-carbon
300 mesh nickel grids (Agar Scientific), semi-dried and repeatedly
washed with PBS prior to staining with 2% uranyl acetate solution for
20 s. The grids were washed and examined using a JEOL 1200ex
transmission electron microscope operating at 80 kV. Thin-section
electron microscopy was carried out according to the method of
Shimizu et al. (1996). Briefly, Huh7 cells containing the FK5.1neo
replicon were transduced with BacC-p7(1b) or BacE1-p7(1b) for 72 h
at 37 uC. Cultured cells were fixed in 2.5% glutaraldehyde, post-fixed
with 1% osmium tetroxide, treated with 2% uranyl acetate,
dehydrated in ethanol, and embedded in araldite-propylene oxide.
Ultrathin sections were stained with lead citrate.
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